Compare FELE & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FELE | LGND |
|---|---|---|
| Founded | 1944 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.9B |
| IPO Year | N/A | 1992 |
| Metric | FELE | LGND |
|---|---|---|
| Price | $96.04 | $188.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $107.00 | ★ $144.71 |
| AVG Volume (30 Days) | ★ 233.3K | 139.7K |
| Earning Date | 10-28-2025 | 08-05-2025 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.07 | N/A |
| Revenue | ★ $2,110,140,000.00 | $181,488,000.00 |
| Revenue This Year | $7.80 | $18.41 |
| Revenue Next Year | $4.77 | $18.87 |
| P/E Ratio | $31.30 | ★ N/A |
| Revenue Growth | 5.06 | ★ 53.40 |
| 52 Week Low | $78.87 | $81.74 |
| 52 Week High | $109.97 | $129.90 |
| Indicator | FELE | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 45.58 |
| Support Level | $92.20 | $179.65 |
| Resistance Level | $97.44 | $192.44 |
| Average True Range (ATR) | 2.16 | 6.57 |
| MACD | 0.30 | -2.06 |
| Stochastic Oscillator | 69.99 | 31.70 |
Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.